Search Results

Displaying Results 5701-5725 of 9553 "'ID'"

Feb 18, 2026, 07:17 ET Implantica presents the Year-end Report (Q4 2025) on February 25 at 15:00 CET

wish to participate via teleconference, please register on the link below. After registration, you will be provided the phone number and a conference ID to access the conference.

More news about: Implantica


Feb 18, 2026, 07:13 ET Blokees Pamerkan Beragam Portofolio Produk di Ajang Toy Fair New York 2026

multimedia:https://www.prnewswire.com/id/rilis-berita/blokees-pamerkan-beragam-portofolio-produk-di-ajang-toy-fair-new-york-2026-302691493.htmlSOURCE

More news about: Blokees


Feb 18, 2026, 07:00 ET Finding Hope for Frizzle (FRRS1L) and Apertura Gene Therapy Announce License Agreement for the Development of a Gene Therapy Using TfR1 CapX, an AAV Capsid Designed to Target the Central Nervous System

increased whole-genome sequence testing. The gene is now included in the screening for infantile epilepsy and dyskinesia (Genetic Testing Registry test ID GTR000551789.3). Clinically, children with FRRS1L disorder experience an onset of seizures from approximately 6 to 24 months of age. Global developmental

More news about: Apertura Gene Therapy


Feb 18, 2026, 06:59 ET Dana Incorporated Reports Strong 2025 Financial Results; Reaffirms 2026 Targets Featuring New Business Growth, Increased Margins

conference call can be accessed by telephone from both domestic and international 18ocations using the information provided below:Conference ID: 9943139Participant Toll-Free Dial-In Number: 1 (888) 440-5873Participant Toll Dial-In Number: 1 (646) 960-0319Audio streaming

More news about: Dana Incorporated


Feb 18, 2026, 02:49 ET BioArctic Interim Report for the period October - December 2025

you wish to participate via teleconference, please register on the link below. After registration you will be provided phone numbers and a conference ID to access the conference. You can ask questions verbally via the teleconference.

More news about: BioArctic


Feb 18, 2026, 02:36 ET BioArctic Interim Report for the period October - December 2025

you wish to participate via teleconference, please register on the link below. After registration you will be provided phone numbers and a conference ID to access the conference. You can ask questions verbally via the teleconference.

More news about: BioArctic


Feb 17, 2026, 18:07 ET Rosen Law Firm Encourages Nidec Corporation Investors to Inquire About Securities Class Action Investigation - NJDCY

https://rosenlegal.com/submit-form/?case_id=47559 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected]

More news about: THE ROSEN LAW FIRM, P.A.


Feb 17, 2026, 17:53 ET BYND Investors Have Opportunity to Lead Beyond Meat, Inc. Securities Fraud Lawsuit

https://rosenlegal.com/submit-form/?case_id=16090 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected]

More news about: THE ROSEN LAW FIRM, P. A.


Feb 17, 2026, 16:30 ET JELD-WEN Reports Fourth Quarter and Full Year 2025 Results, Establishes 2026 Guidance

https://investors.jeld-wen.com, or by dialing 888-596-4144 from the United States or +1-646-968-2525 internationally and using ID 4527798. A slide presentation highlighting the Company's results is available on the Investor Relations section of the Company's website.For those

More news about: JELD-WEN Holding, Inc.


Feb 17, 2026, 16:00 ET KDDI Investor News: Rosen Law Firm Encourages KDDI Corporation Investors to Inquire About Securities Class Action Investigation - KDDIY

https://rosenlegal.com/submit-form/?case_id=52883 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected]

More news about: THE ROSEN LAW FIRM, P. A.


Feb 17, 2026, 15:56 ET KD Investors Have Opportunity to Lead Kyndryl Holdings, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm

https://rosenlegal.com/submit-form/?case_id=38139 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected]

More news about: THE ROSEN LAW FIRM, P. A.


Feb 17, 2026, 15:06 ET 100 Tahun WIDIA: Menetapkan dan Merayakan Seabad Solusi Pemotongan Logam

content:https://www.prnewswire.com/id/rilis-berita/100-tahun-widia-menetapkan-dan-merayakan-seabad-solusi-pemotongan-logam-302689899.htmlSOURCE

More news about: Kennametal Inc.


Feb 17, 2026, 15:00 ET PMI Investors Have Opportunity to Lead Picard Medical, Inc. Securities Fraud Lawsuit

https://rosenlegal.com/submit-form/?case_id=52263 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected]

More news about: THE ROSEN LAW FIRM, P. A.


Feb 17, 2026, 14:45 ET GENESIS RENEWS AS TITLE PARTNER OF THE GENESIS INVITATIONAL

status ahead of the 2020 event that brought Woods as the official host and implemented several enhancements to its field and winner benefits."I'd like to thank Genesis for their renewed commitment to The Genesis Invitational," Woods said. "Together with Genesis, we have found new ways to elevate

More news about: Genesis Motor America


Feb 17, 2026, 14:00 ET Shield Therapeutics Announces FDA Approval of ACCRUFeR®, the First and Only Prescription Oral Iron Therapy Approved for Children Age 10 and Older

ACCRUFeR®/FeRACCRU®ACCRUFeR®/FeRACCRU® (ferric maltol) is a novel, stable, non-salt-based oral therapy for adults and children age 10 and older with ID/IDA. The drug has a novel mechanism of absorption compared to other oral iron therapies and has been shown to be an efficacious and well-tolerated therapy

More news about: Shield Therapeutics


Feb 17, 2026, 13:57 ET QURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit

https://rosenlegal.com/submit-form/?case_id=53025 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected]

More news about: THE ROSEN LAW FIRM, P. A.


Feb 17, 2026, 13:12 ET VTGN Investors Have Opportunity to Lead Vistagen Therapeutics, Inc. Securities Fraud Lawsuit

https://rosenlegal.com/submit-form/?case_id=50827 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected]

More news about: THE ROSEN LAW FIRM, P. A.


Feb 17, 2026, 13:04 ET Austrian State Printing Company (OSD): Newly launched e-Passport of Principality of Liechtenstein wins HSP Award 2026

award. It underlines our goal to deliver always the highest quality for our customers all over the world," says Schwendimann.Leading Role in ID Solutions With the Liechtenstein project, OSD reaffirms its position as a leading provider of turn-key identity solutions. From highly secure

More news about: Austrian State Printing Company


Feb 17, 2026, 11:56 ET LightBox Launches City Directories in LightBox Live℠, Raising the Standard for Phase I Environmental Due Diligence

provides authoritative property, ownership, zoning, environmental, and transaction data powered by a proprietary nationwide parcel fabric and the LightBox ID — a standardized identifier that brings clarity and consistency to complex real estate assets. Through its LightBox Live platform and suite of capital

More news about: LightBoxRE


Feb 17, 2026, 11:05 ET Omnicom Named a Leader in Commerce Services by Independent Research Firm

trillions of media, content, cultural, and commerce signals – including those from Flywheel Commerce Cloud – as well as the industry's most advanced ID-less solutions. Combined, its data and identity provide the most comprehensive, high-fidelity view of consumers and their behavior worldwide.Omnicom's

More news about: Omnicom Group Inc.


Feb 17, 2026, 09:00 ET BioMarin to Host Fourth Quarter and Full-Year 2025 Financial Results Conference Call and Webcast on Monday, February 23, 2026, at 4:30pm ET

800-715-9871International Dial-in Number: 646-307-1963Conference Call ID: 4503000  U.S. / Canada Replay Dial-in Number: 800-770-2030International Replay Dial-in Number: 609-800-9909Playback ID: 4503000  Interested parties may access a live audio webcast of the conference

More news about: BioMarin Pharmaceutical Inc.


Feb 17, 2026, 08:00 ET Chesapeake Utilities to Host its Fourth Quarter and Full-Year 2025 Earnings Conference Call and Webcast on February 26, 2026

portion of the call, please use the following dial-in information:Toll-free: 800-245-3047International: 203-518-9765Conference ID: CPKQ425The conference call presentation will also be made available by visiting the

More news about: Chesapeake Utilities Corporation


Feb 17, 2026, 08:00 ET Cryoport to Report Fourth Quarter and Full Year 2025 Financial Results on March 3, 2026

code:Request the "Cryoport Call" or Conference ID: 1189463Live webcast:

More news about: Cryoport, Inc.


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.